Balloon-occluded transarterial chemoembolization using a 1.8-French tip Coaxial microballoon catheter for hepatocellular carcinoma: Technical and safety considerations

References

• TIrie, MKuramochi, NTakahashi. Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure. Cardiovasc Intervent Radiol. 2013;36:706–13.
   PubMed Web of Science ®Google Scholar
• LMondazzi, RBottelli, GBrambilla, ARampoldi, IRezakovic, CZavaglia, et al. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology. 1994;19:1115–23.
   PubMed Web of Science ®Google Scholar
• KTakayasu, YMuramatsu, TMaeda, RIwata, HFurukawa, YMuramatsu, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol. 2001;176:681–8.
   PubMed Web of Science ®Google Scholar
• SMiyayama, OMatsui, MYamashiro, YRyu, KKaito, KOzaki, et al. Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. J Vasc Interv Radiol. 2007;18:365–76.
   PubMed Web of Science ®Google Scholar
• MIkeda, SMaeda, HAshihara, HNagahama, MTanaka, YSasaki. Transcatheter arterial infusion chemotherapy with cisplatin-lipiodol suspension in patients with hepatocellular carcinoma. J Gastroenterol. 2010;45:60–7.
   Google Scholar
• KKamada, TNakanishi, MKitamoto, HAikata, YKawakami, KIto, et al. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion. J Vasc Interv Radiol. 2001;12:847–54.
   Google Scholar
• LMarelli, RStigliano, CTriantos, MSenzolo, ECholongitas, NDavies, et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol. 2007;30:6–25.
   PubMed Web of Science ®Google Scholar
• MHanada, ABaba, YTsutsumishita, TNoguchi, TYamaoka, NChiba, et al. Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis. Cancer Chemother Pharmacol. 2009;64:473–83.
   Google Scholar
• KIkeda, TOkusaka, MIkeda, MMorimoto. Transcatheter arterial chemoembolization with a lipophilic platinum complex SM-11355(miriplatin hydrate)–safety and efficacy in combination with embolizing agents. Gan To Kagaku Ryoho. 2010;37:271–5.
   Google Scholar
• SKishimoto, TNoguchi, TYamaoka, SFukushima, YTakeuchi. In vitro release of SM-11355, cis[((1R,2R)-1,2-cyclohexanediamine-N,N’)bis(myristato)] platinum(II) suspended in lipiodol. Biol Pharm Bull. 2000;23:637–40.
   PubMedGoogle Scholar
• TOkusaka, SOkada, TNakanishi, SFujiyama, YKubo. Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma. Invest New Drugs. 2004;22:169–76.
   Google Scholar
• SKora, HUrakawa, TMitsufuji, AOsame, HHigashihara, TOhki, et al. Warming effect on miriplatin-lipiodol suspension for potential use as a chemotherapeutic agent for transarterial chemoembolization of hepatocellular carcinoma: In vitro study. Hepatol Res. 2013;43:1100–4.
   Google Scholar
• SKora, HUrakawa, TMitsufuji, AOsame, HHigashihara, KYoshimitsu. Warming effect on miriplatin-lipiodol suspension as a chemotherapeutic agent for transarterial chemoembolization for hepatocellular carcinoma: preliminary clinical experience. Cardiovasc Intervent Radiol. 2013;36:1023–9.
   Google Scholar
• MIkeda, SMaeda, JShibata, RMuta, HAshihara, MTanaka, et al. Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma. Oncology. 2004;66:24–31.
   Google Scholar
• YKawamura, KIkeda, MHirakawa, THosaka, MKobayashi, SSaitoh, et al. Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin. Hepatol Res. 2009;39:346–54.
   Google Scholar
• YOno, TYoshimasu, RAshikaga, MInoue, HShindou, KFuji, et al. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Am J Clin Oncol. 2000;23:564–8.
   PubMedGoogle Scholar
• HYodono, KMatsuo, AShinohara. A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma. Anticancer Drugs. 2011;22:277–82.
   Google Scholar